Literature DB >> 29122905

Healthy donor faecal transplant for corticosteroid non-responsive severe alcoholic hepatitis.

Cyriac Abby Philips1, Nikhil Phadke2, Karthik Ganesan3, Philip Augustine4.   

Abstract

Patients with severe alcoholic hepatitis (SAH) have high mortality in the presence of steroid unresponsiveness in the absence of clear treatment recommendations. Liver transplantation is the curative option in such cases but is controversial in the wake of severe infections, post-transplant recidivism and long waiting on deceased donor listing. Animal and human studies have shed light on the beneficial effects of gut microbiota modulation in alcoholic liver disease. We present the first report of faecal microbiota transplantation (FMT) in a steroid non-responder in whom, clinical, biochemical and liver disease severity scores improved post-FMT and demonstrate distinct bacterial population changes pre-FMT and post-FMT. Healthy donor FMT could be safe and efficacious in SAH not responding to corticosteroid treatment, as a bridge to liver transplantation (LT) or in candidates who are unwilling or not ideal for LT for improvement in short-term transplant free survival. Larger controlled studies are required for confirmation. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  alcoholic liver disease; cirrhosis; portal hypertension

Mesh:

Substances:

Year:  2017        PMID: 29122905      PMCID: PMC5695424          DOI: 10.1136/bcr-2017-222310

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study.

Authors:  Cyriac Abby Philips; Apurva Pande; S Murali Shasthry; Kapil Dev Jamwal; Vikas Khillan; Shivendra Singh Chandel; Guresh Kumar; Manoj K Sharma; Rakhi Maiwall; Ankur Jindal; Ashok Choudhary; Md Shabbir Hussain; Shvetank Sharma; Shiv K Sarin
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-02       Impact factor: 11.382

2.  Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.

Authors:  Gladys Ferrere; Laura Wrzosek; Frédéric Cailleux; Williams Turpin; Virginie Puchois; Madeleine Spatz; Dragos Ciocan; Dominique Rainteau; Lydie Humbert; Cindy Hugot; Françoise Gaudin; Marie-Louise Noordine; Véronique Robert; Dominique Berrebi; Muriel Thomas; Sylvie Naveau; Gabriel Perlemuter; Anne-Marie Cassard
Journal:  J Hepatol       Date:  2016-11-25       Impact factor: 25.083

3.  Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.

Authors:  Jasmohan S Bajaj; Zain Kassam; Andrew Fagan; Edith A Gavis; Eric Liu; I Jane Cox; Raffi Kheradman; Douglas Heuman; Jessica Wang; Thomas Gurry; Roger Williams; Masoumeh Sikaroodi; Michael Fuchs; Eric Alm; Binu John; Leroy R Thacker; Antonio Riva; Mark Smith; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Hepatology       Date:  2017-10-30       Impact factor: 17.425

4.  Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.

Authors:  Philippe Mathurin; John O'Grady; Robert L Carithers; Martin Phillips; Alexandre Louvet; Charles L Mendenhall; Marie-José Ramond; Sylvie Naveau; Willis C Maddrey; Timothy R Morgan
Journal:  Gut       Date:  2010-10-12       Impact factor: 23.059

5.  Durable coexistence of donor and recipient strains after fecal microbiota transplantation.

Authors:  Simone S Li; Ana Zhu; Vladimir Benes; Paul I Costea; Rajna Hercog; Falk Hildebrand; Jaime Huerta-Cepas; Max Nieuwdorp; Jarkko Salojärvi; Anita Y Voigt; Georg Zeller; Shinichi Sunagawa; Willem M de Vos; Peer Bork
Journal:  Science       Date:  2016-04-29       Impact factor: 47.728

6.  Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial.

Authors:  Laurent Spahr; Jean-François Lambert; Laura Rubbia-Brandt; Yves Chalandon; Jean-Louis Frossard; Emiliano Giostra; Antoine Hadengue
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 7.  Diagnosis and management of alcoholic hepatitis.

Authors:  Umair Sohail; Sanjaya K Satapathy
Journal:  Clin Liver Dis       Date:  2012-11       Impact factor: 6.126

8.  Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.

Authors:  M Llopis; A M Cassard; L Wrzosek; L Boschat; A Bruneau; G Ferrere; V Puchois; J C Martin; P Lepage; T Le Roy; L Lefèvre; B Langelier; F Cailleux; A M González-Castro; S Rabot; F Gaudin; H Agostini; S Prévot; D Berrebi; D Ciocan; C Jousse; S Naveau; P Gérard; G Perlemuter
Journal:  Gut       Date:  2015-12-07       Impact factor: 23.059

Review 9.  Emerging concepts in alcoholic hepatitis.

Authors:  Phoenix Fung; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2017-04-28
  9 in total
  4 in total

1.  Fecal Microbiome Distinguishes Alcohol Consumption From Alcoholic Hepatitis But Does Not Discriminate Disease Severity.

Authors:  Ekaterina Smirnova; Puneet Puri; Mark D Muthiah; Kalyani Daitya; Robert Brown; Naga Chalasani; Suthat Liangpunsakul; Vijay H Shah; Kayla Gelow; Mohammed S Siddiqui; Sherry Boyett; Faridoddin Mirshahi; Masoumeh Sikaroodi; Patrick Gillevet; Arun J Sanyal
Journal:  Hepatology       Date:  2020-07       Impact factor: 17.425

Review 2.  Microbiota reprogramming for treatment of alcohol-related liver disease.

Authors:  Mohamed Tausif Siddiqui; Gail A M Cresci
Journal:  Transl Res       Date:  2020-07-17       Impact factor: 7.012

Review 3.  Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment.

Authors:  Dario Spanu; Andrea Pretta; Eleonora Lai; Mara Persano; Clelia Donisi; Stefano Mariani; Marco Dubois; Marco Migliari; Giorgio Saba; Pina Ziranu; Valeria Pusceddu; Marco Puzzoni; Giorgio Astara; Mario Scartozzi
Journal:  World J Hepatol       Date:  2022-07-27

Review 4.  Fecal microbiota transplantation in cancer management: Current status and perspectives.

Authors:  Danfeng Chen; Jingyi Wu; Duochen Jin; Bangmao Wang; Hailong Cao
Journal:  Int J Cancer       Date:  2018-12-30       Impact factor: 7.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.